Klinikiniai Sprendimai UAB
- Address
- P. Luksio G. 3, Kauno M. Sav., 49387 Kaunas, Lithuania
Klinikiniai Sprendimai UAB - Cardiovascular Disease Research
Klinikiniai Sprendimai UAB is a specialized clinical research center focused on advancing cardiovascular disease prevention and treatment through participation in multinational Phase 3 trials. The center demonstrates particular expertise in evaluating novel therapeutic interventions for high-risk cardiovascular populations, including both primary prevention strategies and management of cardiac arrhythmias.
- Primary prevention of atherosclerotic cardiovascular disease (ASCVD) with lipid-lowering therapies
- Prevention of cardioembolic events in patients with atrial fibrillation
- Novel anticoagulation strategies and stroke prevention research
The center's research portfolio includes evaluation of innovative approaches to major adverse cardiovascular event (MACE) prevention in high-risk populations and comparative effectiveness studies of anticoagulant therapies for patients with atrial fibrillation. Their participation in large-scale, active-controlled trials demonstrates capability in managing complex cardiovascular protocols and recruiting diverse patient populations requiring long-term cardiovascular risk management.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 6 by active trials.
- 1Arrowhead Pharmaceuticals Inc.2active
lock +5 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Arrowhead Pharmaceuticals Inc.3trials
lock +5 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 79 other sites in Lithuania
Therapeutic Area Benchmark — Lithuania
Select a therapeutic area to compare against other sites in Lithuania.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Lithuania
Market Share
Country: Lithuania
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Klinikiniai Sprendimai UAB
lock Showing 1 of 19 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Barzolvolimab in Participants with Cold-Induced Urticaria and Symptomatic Dermographism | Celldex Therapeutics Inc. | Phase III | Recruiting | Apr 2026 | — |
IMP list
lock Showing 1 of 15 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Barzolvolimab | 3 | Unknown | 2025-04-04 | 2026-04-20 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.